Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-25-284586
Filing Date
2025-11-17
Accepted
2025-11-17 16:01:45
Documents
13
Period of Report
2025-12-19

Document Format Files

Seq Description Document Type Size
1 DEF 14A acet-20251117.htm   iXBRL DEF 14A 326869
2 GRAPHIC img106677955_0.jpg GRAPHIC 11570
3 GRAPHIC img106677955_1.jpg GRAPHIC 195159
4 GRAPHIC img106677955_2.jpg GRAPHIC 235803
  Complete submission text file 0001193125-25-284586.txt   1685827

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acet-20251117.xsd EX-101.SCH 40863
15 EXTRACTED XBRL INSTANCE DOCUMENT acet-20251117_htm.xml XML 1293
Mailing Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116
Business Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38359 | Film No.: 251490991
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)